Viatris Innovation GmbH clinical trials

A subsidiary of Viatris Inc.

The registry lists 24 studies whose lead sponsor is Viatris Innovation GmbH. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 15, 2026.

Studies

Recruiting first, then most recently updated. Showing 24 of 24. All Viatris Inc. studies →

• Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus ErythematosusEnrolling by invitationNCT06475742Phase 3

  Sponsor listed in the registry: Viatris Innovation GmbH

• A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular TreatmentRecruitingNCT07201129Phase 3

  Sponsor listed in the registry: Viatris Innovation GmbH

• Selatogrel Outcome Study in Suspected Acute Myocardial InfarctionEnrolling by invitationNCT04957719Phase 3

  Sponsor listed in the registry: Viatris Innovation GmbH

• A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Chinese Adults With Chronic Coronary SyndromeRecruitingNCT07615868Phase 1

  Sponsor listed in the registry: Viatris Innovation GmbH

• A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus ErythematosusActive, not recruitingNCT05672576Phase 3

  Sponsor listed in the registry: Viatris Innovation GmbH

• A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus ErythematosusActive, not recruitingNCT05648500Phase 3

  Sponsor listed in the registry: Viatris Innovation GmbH

• A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery DiseaseCompletedNCT03384966Phase 2

  Sponsor listed in the registry: Viatris Innovation GmbH

• Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus ErythematosusCompletedNCT02472795Phase 1/2

  Sponsor listed in the registry: Viatris Innovation GmbH

• A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Heart AttackCompletedNCT03487445Phase 2

  Sponsor listed in the registry: Viatris Innovation GmbH

• Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus ErythematosusCompletedNCT03742037Phase 2

  Sponsor listed in the registry: Viatris Innovation GmbH

• A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Japanese and Caucasian Healthy ParticipantsCompletedNCT07133191Phase 1

  Sponsor listed in the registry: Viatris Innovation GmbH

• A Trial to Evaluate the Absolute Bioavailability of Cenerimod in Healthy Male ParticipantsCompletedNCT07301723Phase 1

  Sponsor listed in the registry: Viatris Innovation GmbH

• Single Oral Dose of 4 mg Cenerimod in Healthy Japanese and Caucasian SubjectsCompletedNCT04052360Phase 1

  Sponsor listed in the registry: Viatris Innovation GmbH

• Clinical Study to Investigate Safety and Effects on Heart Rate, Blood Pressure, and Pharmacokinetic Interactions of ACT-334441TerminatedNCT02479204Phase 1

  Sponsor listed in the registry: Viatris Innovation GmbH

• A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of CenerimodCompletedNCT04819464Phase 1

  Sponsor listed in the registry: Viatris Innovation GmbH

• A Study to Evaluate Cenerimod in Healthy Male SubjectsCompletedNCT02914223Phase 1

  Sponsor listed in the registry: Viatris Innovation GmbH

• To Study the Effect of Cenerimod on the Electrical Activity of the Heart, in Men and Women. To Study the Effect of Cenerimod on the Use of Oral Contraceptives in Women. To Study the Effect That Charcoal Has on the Elimination of Cenerimod From the Body, in Women and Men.CompletedNCT04255277Phase 1

  Sponsor listed in the registry: Viatris Innovation GmbH

• The Effect of Severe Kidney Impairment on Cenerimod PharmacokineticsCompletedNCT05004311Phase 1

  Sponsor listed in the registry: Viatris Innovation GmbH

• The Effect of Reduced Liver Function on Selatogrel PharmacokineticsCompletedNCT04406896Phase 1

  Sponsor listed in the registry: Viatris Innovation GmbH

• A Comparative Study of Selatogrel (ACT-246475) Formulations in Healthy SubjectsCompletedNCT04557280Phase 1

  Sponsor listed in the registry: Viatris Innovation GmbH

• A Study to Investigate the Effect of Rifampicin on the Uptake and Breakdown of ACT-246475 in Healthy SubjectsCompletedNCT03814200Phase 1

  Sponsor listed in the registry: Viatris Innovation GmbH

• A Study to Evaluate ACT-246475 Fate in Healthy Male SubjectsCompletedNCT03593278Phase 1

  Sponsor listed in the registry: Viatris Innovation GmbH

• A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy SubjectsCompletedNCT03430661Phase 1

  Sponsor listed in the registry: Viatris Innovation GmbH

• A Study Conducted in Healthy Male Subjects to Investigate the Safety and Tolerability of AC-76, Its Fate in the Body, and Its Effect on the BodyCompletedNCT03173625Phase 1

  Sponsor listed in the registry: Viatris Innovation GmbH